Skip to content

The Effect of Sevoflurane on Haemodynamics

The Effect of Sevoflurane on Cardiac Output, Mean Systemic Filling Pressure, and Vascular Resistances in Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06707077
Enrollment
40
Registered
2024-11-27
Start date
2024-12-05
Completion date
2025-03-05
Last updated
2025-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Output, Sevoflurane, Vascular Resistance, Venous Return

Keywords

sevoflurane, cardiac output, mean systemic filling pressure, vascular resistance

Brief summary

Cardiac output (CO) is measured using Mostcare. Mean systemic filling pressure (MSFP) and vascular resistances are calculated using venous return curves constructed by measuring steady-state arterial and venous pressures and cardiac output (CO) during inspiratory hold manoeuvres at increasing plateau pressures. Measurements are performed at three incremental levels of targeted sevoflurane concentrations.

Detailed description

Tracheal intubation is performed after anesthesia induction with sevoflurane. Radial arterial is cannulated and pressure transducer is connected to MostCare (core technique PRAM). HR, MAP, CVP, CO, SVR, PPV, and dp/dt are recorded at three incremental levels of targeted sevoflurane concentrations. MSFP and vascular resistances are calculated.

Interventions

None listed

Sponsors

Children's Hospital of Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* American Association of Anesthesiologists (ASA)physical status score I-III * major elective surgery that dictates the use of invasive hemodynamic monitoring including CVP and continuous arterial blood pressure monitoring.

Exclusion criteria

* symptomatic peripheral vascular disease or pulmonary disease * aberrant cardiovascular anatomy * significant valvular regurgitation * severe arrhythmia

Design outcomes

Primary

MeasureTime frameDescription
cardiac outputHemodynamic parameters are recorded after 15 min of equilibration at each sevoflurane concentration.Cardiac output is monitored using Mostcare via a radial arterial catheter connected to the pressure transducer.
mean systemic filling pressureHemodynamic parameters are recorded after 15 min of equilibration at each sevoflurane concentration.Mean systemic filling pressure (MSFP) is calculated using venous return curve constructed by measuring steady-state arterial and venous pressures and CO during inspiratory hold manoeuvres at increasing plateau pressures. The CVP and CO data are fitted by linear regression to define the venous return curve. We define MSFP by extrapolation to zero flow.
vascular resistanceHemodynamic parameters are recorded after 15 min of equilibration at each sevoflurane concentration.Total systemic vascular resistance (Rsys) is calculated as the ratio of the pressure difference between mean Pa and mean CVP and CO. The resistance downstream to MSFP is taken to reflect the resistance to venous return (Rv) and is calculated as the ratio of the pressure difference between MSFP and CVP and CO. Systemic arterial resistance (Ra) is taken to be the difference between systemic and venous resistance.

Secondary

MeasureTime frameDescription
mean arterial pressureHemodynamic parameters are recorded after 15 min of equilibration at each sevoflurane concentration.Systemic arterial blood pressure is monitored via a radial arterial catheter connected to a pressure transducer.
dP/dtHemodynamic parameters are recorded after 15 min of equilibration at each sevoflurane concentration.dP/dt is obtained from Mostcare.
central venous pressureHemodynamic parameters are recorded after 15 min of equilibration at each sevoflurane concentration.CVP is measured with a catheter inserted through the right internal jugular vein.
pulse pressure variationHemodynamic parameters are recorded after 15 min of equilibration at each sevoflurane concentration.PPV is obtained from Mostcare.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026